An electronic alert to reduce excessive prescribing of short-acting beta2-agonists for people with asthma in East London: a retrospective case-control study using routine primary care data

S. McKibben (London, United Kingdom), A. Bush (London, United Kingdom), M. Thomas (Southampton, United Kingdom), C. Griffiths (London, United Kingdom)

Source: Virtual Congress 2020 – Digital health interventions in respiratory medicine
Session: Digital health interventions in respiratory medicine
Session type: E-poster session
Number: 1364
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. McKibben (London, United Kingdom), A. Bush (London, United Kingdom), M. Thomas (Southampton, United Kingdom), C. Griffiths (London, United Kingdom). An electronic alert to reduce excessive prescribing of short-acting beta2-agonists for people with asthma in East London: a retrospective case-control study using routine primary care data. 1364

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The use of electronic alerts in primary care to identify the over-prescription of short-acting beta2-agonists in people with asthma: a systematic review
Source: International Congress 2017 – Primary care management of asthma and COPD
Year: 2017



Change in asthma management recommendations is associated with reduction of reliever drugs in the real-world setting: a longitudinal retrospective claims data analysis in Burgenland
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020

Dispensed asthma therapy and medical resource utilisation in asthma patients: results from the L777 observational study
Source: Annual Congress 2009 - Epidemiology of asthma
Year: 2009


Are smokers with acute cough in primary care prescribed antibiotics more often, and to what benefit? An observational study in 13 European countries
Source: Eur Respir J 2010; 35: 761-767
Year: 2010



Prescription of antitussives in asthma: A cross-sectional study in primary care in France and in Italy
Source: Annual Congress 2012 - Epidemiology of various respiratory diseases
Year: 2012

“I don’t think there’s a simple way of doing it:” the use of an electronic alert to identify excessive prescribing of short-acting beta2-agonists for people with asthma – a qualitative study with asthma experts and primary care staff
Source: Virtual Congress 2020 – Diagnosis and management of airways disease in primary care
Year: 2020




Predictors of excessive short-acting beta2-agonist use and asthma exacerbations: a retrospective analysis of a Polish prescription database.
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020


Medication use and disease control of asthma patients in Flanders: a cross-sectional community pharmacy study
Source: Eur Respir J 2005; 26: Suppl. 49, 47s
Year: 2005

Can asthma liason nurses reduce unscheduled care in a deprived multi-ethnic population? ELECTRA: the east London controlled trial for high-risk asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 621s
Year: 2002

Healthcare costs associated with short-acting ß2-agonist use in asthma: an observational UK study from the SABINA global programme
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021


What predicts poor collection of medication among children with asthma? A case-control study
Source: Eur Respir J 2002; 20: 1464-1469
Year: 2002



Does the provision of a written action plan in the emergency department (ED) improve adherence to physicians‘ recommendations and asthma control in children with acute asthma? A randomized controlled trial
Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma
Year: 2008


General practice and office spirometry in asthma and COPD: preliminary data from the prospective, randomised, comparative ²SPACE² Italian study
Source: Eur Respir J 2004; 24: Suppl. 48, 87s
Year: 2004

SABINA: global programme to evaluate prescriptions and clinical outcomes related to short-acting ß2-agonist use in asthma
Source: Eur Respir J, 55 (2) 1901858; 10.1183/13993003.01858-2019
Year: 2020



Reasons for inhaled corticosteroid non-adherence disclosed by African American adults during primary care visits for uncontrolled asthma
Source: Virtual Congress 2020 – Novel insights into nursing interventions for managing patients with asthma and COPD
Year: 2020




Patterns of risk of death and asthma-related adverse outcomes in adult asthma patients receiving long-acting β2-agonist (LABA) therapy: results from the UK general practice research database (GPRD)
Source: Annual Congress 2009 - Asthma treatment and control strategies in primary care
Year: 2009


Prescribing patterns of inhaled corticosteroids in asthma amongst primary care physicians in Singapore
Source: Virtual Congress 2021 – Primary care organisation and epidemiology
Year: 2021

A survey of asthma severity, comorbidities and treatments in a paediatric primary care cohort in the UK
Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care
Year: 2009


Factors related to discontinuous use of inhaled drugs in COPD patients: A population-based cohort study in Lazio (Italy)
Source: Annual Congress 2012 - Healthcare utilisation and treatment of asthma and COPD
Year: 2012


Asthma severity, poor control, co-morbidities and prior resource use determined omalizumab prescriptions in a nested case-control study with US claims data
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015